Inaba Taro
Fondateur chez Remiges Ventures Inc.
Profil
Inaba Taro is a managing partner and managing director at Remiges Ventures Inc., a company he founded in 2014.
He is also currently a director at Capacity Bio, Inc. In the past, he worked as a general manager at Mitsui & Co., Ltd.
from 2009 to 2014.
Mr. Taro received his undergraduate degree from Kyoto University in 1991 and his MBA from the European University at Saint Petersburg in 1995.
Postes actifs de Inaba Taro
Sociétés | Poste | Début |
---|---|---|
Remiges Ventures Inc.
Remiges Ventures Inc. Investment ManagersFinance Remiges Ventures Inc. (Remiges Ventures) is a venture capital firm founded in 2014 by Taro Inaba. It is headquartered in Cambridge, United States. | Fondateur | 01/06/2014 |
Capacity Bio, Inc.
Capacity Bio, Inc. BiotechnologyHealth Technology Capacity Bio, Inc. is a biotech company based in an undisclosed location. The American company is focused on developing a first-in-class mitophagy therapeutic platform and an advanced analytical toolkit to characterize mitochondria. The company was founded by Amy Wang, Stan Louie, and Kathy Rodgers, and the CEO is Kenneth Nicholas Horne. | Directeur/Membre du Conseil | - |
Anciens postes connus de Inaba Taro
Sociétés | Poste | Fin |
---|---|---|
MITSUI & CO., LTD. | Corporate Officer/Principal | 01/05/2014 |
Formation de Inaba Taro
European University at Saint Petersburg | Masters Business Admin |
Kyoto University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
MITSUI & CO., LTD. | Process Industries |
Entreprise privées | 2 |
---|---|
Remiges Ventures Inc.
Remiges Ventures Inc. Investment ManagersFinance Remiges Ventures Inc. (Remiges Ventures) is a venture capital firm founded in 2014 by Taro Inaba. It is headquartered in Cambridge, United States. | Finance |
Capacity Bio, Inc.
Capacity Bio, Inc. BiotechnologyHealth Technology Capacity Bio, Inc. is a biotech company based in an undisclosed location. The American company is focused on developing a first-in-class mitophagy therapeutic platform and an advanced analytical toolkit to characterize mitochondria. The company was founded by Amy Wang, Stan Louie, and Kathy Rodgers, and the CEO is Kenneth Nicholas Horne. | Health Technology |